Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies
of CNS Disorders (R33)
Release Date: August 7, 2006
Announcement Number: PA-06-462
Application Receipt Date:
October 1, 2006
February 16, 2007
June 16, 2007
October 16, 2007
February 16, 2008
June 16, 2008
October 16, 2008
February 16, 2009
June 16, 2009
Funding Contact: Debra Babcock, MD., Ph.D.
Program Area: Systems and Cognitive Neuroscience
Brief Description:
This Funding Opportunity Announcement (FOA) issued by the National Institute of Mental Health (NIMH), the National Institute
on Aging (NIA), National Institute of Alcohol Abuse and Alcoholism (NIAAA), and the National Institute on Drug Abuse (NIDA)
of the National Institutes of Health (NIH), invites Phase II Developmental (R33) grant applications from organizations/institutions
that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed
tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies,
model development, or clinical studies.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |